{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Japan Drug Manufacturers - Specialty & Generic news", "home_page_url": "https://sharemaestro.com/newsreel/jp/healthcare/drug-manufacturers-specialty-generic/", "feed_url": "https://sharemaestro.com/newsreel/jp/healthcare/drug-manufacturers-specialty-generic/feed.json", "description": "Latest Drug Manufacturers - Specialty & Generic company headlines from Japan, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:1db721410e07ce8559f788b5479910ae5b24c12c531a268cfe9a60b87c9cc152", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Takeda Pharmaceutical (TSE:4502) Is Using AI To Advance Three Late Stage Medicines", "content_text": "Takeda Pharmaceutical (TSE:4502) Is Using AI To Advance Three Late Stage Medicines", "date_published": "2026-08-12T06:41:23+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:2c6ce9b6b9180d28e3a6cba7632ef1d84608a139e70ffd49856b59f3cf7b7ff4", "url": "https://finance.yahoo.com/healthcare/articles/takeda-pharmaceutical-tse-4502-wins-231825907.html", "external_url": "https://finance.yahoo.com/healthcare/articles/takeda-pharmaceutical-tse-4502-wins-231825907.html", "title": "Takeda Pharmaceutical (TSE:4502) Wins ORZEYFUL Approval, Where Does Fair Value Sit?", "content_text": "Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after U.S. regulators approved ORZEYFUL for adult narcolepsy type 1, and the company also issued new impairment guidance and reaffirmed its fiscal 2027 earnings outlook. See our latest analysis for Takeda Pharmaceutical. The ORZEYFUL approval and refreshed guidance arrive as Takeda Pharmaceutical trades at \u00a55,582, with a 7 day share price return of 5.6% and a year to date share price return of 13.6%. Over a longer hor", "date_published": "2026-08-11T23:18:25+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:87824ab92356055a0ece70d921e4dda167a67ceac20080739f8e2ea922d775c4", "url": "https://finance.yahoo.com/video/takeda-cso-chris-arendt-transforming-132622044.html", "external_url": "https://finance.yahoo.com/video/takeda-cso-chris-arendt-transforming-132622044.html", "title": "Takeda CSO Chris Arendt on Transforming Drug Discovery & the R&D Pipeline", "content_text": "Takeda is entering one of the most pivotal moments in its 245-year history, with a late-stage pipeline poised to transform patient outcomes across three therapeutic areas. Chief Scientific Officer Chris Arendt goes Inside the ICE House to discuss the science behind drug candidates targeting narcolepsy, polycythemia vera, and psoriasis. He explores how AI and computational technologies are reshaping drug discovery and why building the right data foundation is critical to supercharging Takeda's R&D engine. View Comments", "date_published": "2026-08-10T13:26:22+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:bb20235fb3d4a732a4f7a93ed56a0182519c1f436e1b4ec4fcba1cf4c65edb38", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5XWWVtelliYkVlSmQ0azBiRURINEVjTTVOa3p6cXN2S01Jb1Zfcjc1dGpRM2ROT282bTJ6cGxSUVlreUlYeFhreWN5QXBOaUFNNkhvNQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5XWWVtelliYkVlSmQ0azBiRURINEVjTTVOa3p6cXN2S01Jb1Zfcjc1dGpRM2ROT282bTJ6cGxSUVlreUlYeFhreWN5QXBOaUFNNkhvNQ?oc=5", "title": "Takeda Pharmaceutical Company Limited (4502.T) stock price, news, quote and history", "content_text": "Takeda Pharmaceutical Company Limited (4502.T) stock price, news, quote and history", "date_published": "2026-08-08T06:15:29+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:71b3f357b34fe62720605e242a88d83e80db1f84b99f4be3c7270a96cfcdfde6", "url": "https://finance.yahoo.com/healthcare/articles/dnli-q2-loss-narrows-avlayah-183100129.html", "external_url": "https://finance.yahoo.com/healthcare/articles/dnli-q2-loss-narrows-avlayah-183100129.html", "title": "DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum", "content_text": "Denali Therapeutics DNLI reported a second-quarter 2026 loss of 68 cents per share, narrower than the Zacks Consensus Estimate of a loss of 73 cents. The company incurred a loss of 72 cents in the year-ago quarter. In late March, Denali secured a major regulatory win with the FDA approval of its lead pipeline candidate tividenofusp alfa-eknm, under the brand name Avlayah, for the treatment of Hunter Syndrome (MPS II). The FDA granted accelerated approval to Avlayah, marking the first new treatment option in nearly 20 years for patients with Hunter syndrome, a rare lysosomal storage disorder. I", "date_published": "2026-08-07T18:31:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:68f4d08f0b0a563b61397e00d16a20e9c32b41e90672f91defce9f5bdfaf0a72", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9VNy1kRFNkNE9pdVRfV29fTEVONXpuajBWLThyYWxVRURfb2NjaG55Vzg5QkdvaHg1Rnpld2lvZTNpdHFXbWdnNi1JQmtVbFNpeXVYbUpya0xSTktlTS1wMmZ6bXBraDRSREVaVg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9VNy1kRFNkNE9pdVRfV29fTEVONXpuajBWLThyYWxVRURfb2NjaG55Vzg5QkdvaHg1Rnpld2lvZTNpdHFXbWdnNi1JQmtVbFNpeXVYbUpya0xSTktlTS1wMmZ6bXBraDRSREVaVg?oc=5", "title": "TAK|Takeda Pharmaceutical Co Ltd|Price:17.450|Chg%:+0.430", "content_text": "TAK|Takeda Pharmaceutical Co Ltd|Price:17.450|Chg%:+0.430", "date_published": "2026-08-07T07:00:00+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:b41f41ee6519bbdd622f55dd008883d360f918c47575725191e2e590eeacec5a", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Takeda (TSE:4502) Stock Struggles To Convert Revenue Growth Into Lasting Profit", "content_text": "Takeda (TSE:4502) Stock Struggles To Convert Revenue Growth Into Lasting Profit", "date_published": "2026-07-31T07:00:00+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Earnings", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:56a19eedd888a68cbbfdf4f7c7f527c61eef447b9480ac5dcfcf5f09c13b080a", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNdGE0eHQ1TWFXbVFZTDdPMFl3VXdRRFBMY1I1LXVkb2VHbmRoX2RTTHNDMjdHQVVqbGhCbE8wUVY0TFppeXJoQmtsR0pyVDhETGg2X0FXU1lxU0NRbDJqNkh6MW5FcW5POTR5OHVKR25vUTd6TGNSSUhBZzViOHRRYTk2cFFGUllvZkE4NDl0aGRvWDhpQl9fOGg0ZFBDX2FZenNEekZZeUZlVUI1OHd6SXFSalJGelV4bElHazZxNUZMeUdrd0E?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNdGE0eHQ1TWFXbVFZTDdPMFl3VXdRRFBMY1I1LXVkb2VHbmRoX2RTTHNDMjdHQVVqbGhCbE8wUVY0TFppeXJoQmtsR0pyVDhETGg2X0FXU1lxU0NRbDJqNkh6MW5FcW5POTR5OHVKR25vUTd6TGNSSUhBZzViOHRRYTk2cFFGUllvZkE4NDl0aGRvWDhpQl9fOGg0ZFBDX2FZenNEekZZeUZlVUI1OHd6SXFSalJGelV4bElHazZxNUZMeUdrd0E?oc=5", "title": "Takeda Pharmaceutical Co Ltd (TAK) Stock Up 5.1% but GF Value Sa", "content_text": "Takeda Pharmaceutical Co Ltd (TAK) Stock Up 5.1% but GF Value Sa", "date_published": "2026-07-02T07:00:00+00:00", "authors": [{"name": "GuruFocus"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:70eba4944a507130f6315153b764cfe37659d6a52a09b0477172dda4b4065a8d", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOY3BEQzFhQ0I0dTNQTEFZVnRFXzdadzRDNlhRZ2h5cXNCNFVIbnRtVi1Ydnd4TmJHdHBOYmVTWjgwbkQtekZRRTRsRDFTVGJGR2tWbnhpdXRfanZQS0xhZGo4WmRja3l6cG0wN1B5Z3F5ZUR4YzJNYllONmE4bXBsV3hiUjJsRVpJaHc3OEU3cTFQVDlkWTJn?oc=5", "external_url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOY3BEQzFhQ0I0dTNQTEFZVnRFXzdadzRDNlhRZ2h5cXNCNFVIbnRtVi1Ydnd4TmJHdHBOYmVTWjgwbkQtekZRRTRsRDFTVGJGR2tWbnhpdXRfanZQS0xhZGo4WmRja3l6cG0wN1B5Z3F5ZUR4YzJNYllONmE4bXBsV3hiUjJsRVpJaHc3OEU3cTFQVDlkWTJn?oc=5", "title": "Takeda Pharmaceutical: The Downside Was Forecastable (NYSE:TAK)", "content_text": "Takeda Pharmaceutical: The Downside Was Forecastable (NYSE:TAK)", "date_published": "2026-06-11T07:00:00+00:00", "authors": [{"name": "Seeking Alpha"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:cfb4fdaefe4fb364abf44de0ca13afb3f8c943c62387e1ae514fd6e7686d64fa", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNN3NLVTdzd3lJSElxY0pQcjdmM3VqOHJxeUdYZWlqckdFNHZDbVotQldGZDRZSHBiTU91NGctT3dYS2lBN0FRWG5hT01jTUIxNkFsNnRKbE14VXNsWTdGb3pSN19BQkh6endFbUZ2WGFVT3IwMjd0QTZMYTF4OFpvNHZlSVJKZ2k0Z0k5TFd1eE9JcERQTWZyeUlMM21KSVBvWWdCWmhoRUlzeFhZYnZ6MWFkbTB2LXBv?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNN3NLVTdzd3lJSElxY0pQcjdmM3VqOHJxeUdYZWlqckdFNHZDbVotQldGZDRZSHBiTU91NGctT3dYS2lBN0FRWG5hT01jTUIxNkFsNnRKbE14VXNsWTdGb3pSN19BQkh6endFbUZ2WGFVT3IwMjd0QTZMYTF4OFpvNHZlSVJKZ2k0Z0k5TFd1eE9JcERQTWZyeUlMM21KSVBvWWdCWmhoRUlzeFhZYnZ6MWFkbTB2LXBv?oc=5", "title": "Takeda Pharmaceutical Co Ltd (TAK) Shares Fall 4.8% -- GF Value Says Still Overvalued", "content_text": "Takeda Pharmaceutical Co Ltd (TAK) Shares Fall 4.8% -- GF Value Says Still Overvalued", "date_published": "2026-06-01T07:00:00+00:00", "authors": [{"name": "GuruFocus"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:13ffc0a8e672d7d331352b826cc755663b35d96a679863992e315436762c6b82", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNckF0ZTgxZTZ2ejFldFAydkpubF9MRGQzMWRLU0pTOFdzakxOelRiSFNVN2dPTjU1TVdoaHBCbmJMSEszUWNVUUxWdUlraDgxVlB2dGp5TXA1Z21WZmtFNGtkblVfaHBZOW5TM3VqMnhzX1pnNGZWYjNzSVR2dVFDZENyR2owRnF4MTI5MnRJZGR6dUh5RklRZHhKeXAxNWVIWlVyRmpwZ0hseXpnZU02aWdwanNpUHpDSTBfRHpZRHBwSUE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNckF0ZTgxZTZ2ejFldFAydkpubF9MRGQzMWRLU0pTOFdzakxOelRiSFNVN2dPTjU1TVdoaHBCbmJMSEszUWNVUUxWdUlraDgxVlB2dGp5TXA1Z21WZmtFNGtkblVfaHBZOW5TM3VqMnhzX1pnNGZWYjNzSVR2dVFDZENyR2owRnF4MTI5MnRJZGR6dUh5RklRZHhKeXAxNWVIWlVyRmpwZ0hseXpnZU02aWdwanNpUHpDSTBfRHpZRHBwSUE?oc=5", "title": "Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline", "content_text": "Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline", "date_published": "2026-05-14T07:00:00+00:00", "authors": [{"name": "Morningstar"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:8eafc403b2534b9c11d0b7bd47bdaf1d048ac5df38d6e058624050050984b44d", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRkFWZ3o4c21ET2tVMzVGNDFhVS1OZnhIZU5uOEh5akxTT2JuV0ZvaEtLRl9DNHZBS1VwOVZWNlBnZEdYOVYta0ZnbmNmaUhoVDFURjJqT1QyZnBPWjJzenlmUnc5dGhyeW5NUWN0V1JyTE12WEtaVEluUm8wQ1FwLUdXZVFfU1JFTEhha0lmcXcxaF9hd19jcTZmSzY3N1F5cWlPal9jbGNIajNhbFQ4?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRkFWZ3o4c21ET2tVMzVGNDFhVS1OZnhIZU5uOEh5akxTT2JuV0ZvaEtLRl9DNHZBS1VwOVZWNlBnZEdYOVYta0ZnbmNmaUhoVDFURjJqT1QyZnBPWjJzenlmUnc5dGhyeW5NUWN0V1JyTE12WEtaVEluUm8wQ1FwLUdXZVFfU1JFTEhha0lmcXcxaF9hd19jcTZmSzY3N1F5cWlPal9jbGNIajNhbFQ4?oc=5", "title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?", "content_text": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?", "date_published": "2026-05-02T07:00:00+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:7efad26d5de3ebef2344f7b9f45f6adde1e59cc992472b4de0cbbc5295cecc4e", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxQVlhuOWMyU3MybTdKNkN4R0E2WWx5dVZZa3VCSHNzVW9QUHg1b1E3Z3VPNDhWVjJGaXZmeXV5cVk1dnJTVHlhR25pcl9XN2hzdlF0ekJmd0J2Y2duMFhhRVBlSTEzRjVIem51eTVsVkhYcC1MTnhUeFI0M0xFMUpXaXlHLUd0R0ZBWDhiQ3J0UktERDF2bjQxTnN3V1E3VFBIeVBUbmtYQlBsMVBzQmtGYmRKS3JNUUpGenB0d01KY3ZMX2ctcnZkX2FsMi13eXMwMnd3N3loSWtsUjRoZVhaUDBRbXpCYlc2X0cyU2dpSkVXME5RZUN1QTk3WHhhOGtlNWlMZWswQXJNVVBFUzVJbXhNOUtaTXNYaVB1SGZQVS1CM3pxd19WdlU4RWtPRHVjb0E?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxQVlhuOWMyU3MybTdKNkN4R0E2WWx5dVZZa3VCSHNzVW9QUHg1b1E3Z3VPNDhWVjJGaXZmeXV5cVk1dnJTVHlhR25pcl9XN2hzdlF0ekJmd0J2Y2duMFhhRVBlSTEzRjVIem51eTVsVkhYcC1MTnhUeFI0M0xFMUpXaXlHLUd0R0ZBWDhiQ3J0UktERDF2bjQxTnN3V1E3VFBIeVBUbmtYQlBsMVBzQmtGYmRKS3JNUUpGenB0d01KY3ZMX2ctcnZkX2FsMi13eXMwMnd3N3loSWtsUjRoZVhaUDBRbXpCYlc2X0cyU2dpSkVXME5RZUN1QTk3WHhhOGtlNWlMZWswQXJNVVBFUzVJbXhNOUtaTXNYaVB1SGZQVS1CM3pxd19WdlU4RWtPRHVjb0E?oc=5", "title": "Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook", "content_text": "Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook", "date_published": "2026-03-25T07:00:00+00:00", "authors": [{"name": "TradingView"}], "tags": ["Guidance", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:e145c51ead216108633b56b15ebfffddf6c1007fb6ad595877b2a074a3b26f9a", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPV2EwUkxKSVZNaEJLQ0o0NHFHdFZmQ29LTmt1NklBdnVFTHVueHZRTWRTSktZSk1BM1l6LS1sa1RTTXNnOEYtSUcyZ2JBU1V5a0pjRkRiOF9iN1hWNjRqOFpPalRTN0cydVNfbVM1NnB3MERnYmJWOFFKcmM4eE9aMzBabV9mTGgtUUN0dHpTWXM?oc=5", "external_url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPV2EwUkxKSVZNaEJLQ0o0NHFHdFZmQ29LTmt1NklBdnVFTHVueHZRTWRTSktZSk1BM1l6LS1sa1RTTXNnOEYtSUcyZ2JBU1V5a0pjRkRiOF9iN1hWNjRqOFpPalRTN0cydVNfbVM1NnB3MERnYmJWOFFKcmM4eE9aMzBabV9mTGgtUUN0dHpTWXM?oc=5", "title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?", "content_text": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?", "date_published": "2026-01-31T08:00:00+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:e123934ffcd57f1cc9d8d156f4219b14e0ea73c27c3093d6164811e2835703dc", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5NcVB5QjBESXJYMGtyOWVLN2dqTEpKUWdkMjJCdzBxaHZtNU9yRmR2aXN2dkpmTHRSb0tnV0ZjNWVYU3RzSk9jR3M0blBNWXJESHBaWVdn?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5NcVB5QjBESXJYMGtyOWVLN2dqTEpKUWdkMjJCdzBxaHZtNU9yRmR2aXN2dkpmTHRSb0tnV0ZjNWVYU3RzSk9jR3M0blBNWXJESHBaWVdn?oc=5", "title": "Takeda Pharmaceutical (TAK) Stock Price Today: $17.49", "content_text": "Takeda Pharmaceutical (TAK) Stock Price Today: $17.49", "date_published": "2025-12-16T20:17:42+00:00", "authors": [{"name": "Gotrade"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:3977bf386fe97118d94ce4f32f075e4ac92838478654cd17bf0fa8dc51ffc0e5", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLXByN3k4OFptdGx4TUkxWjBfMWE1c1l0YTR6XzNmekpHMFA0ekI4aDJhU2NmZnJxT3FJVG04SVBaSUd2V1hyUjFBNzFWTi1FV2NYNE1mTmlmcWNpcHBrZ3BMb3MzMncwTU1NVzdBUy1neldtcXY3bTljTnZUZ3FHNkR1TlB5dFhQRWdLWFNxTVpVZDhaeDdSOFZNY05kOUozenROb1ZDSWE3dllEYS1IMldsTVBENEJrYXNTcA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLXByN3k4OFptdGx4TUkxWjBfMWE1c1l0YTR6XzNmekpHMFA0ekI4aDJhU2NmZnJxT3FJVG04SVBaSUd2V1hyUjFBNzFWTi1FV2NYNE1mTmlmcWNpcHBrZ3BMb3MzMncwTU1NVzdBUy1neldtcXY3bTljTnZUZ3FHNkR1TlB5dFhQRWdLWFNxTVpVZDhaeDdSOFZNY05kOUozenROb1ZDSWE3dllEYS1IMldsTVBENEJrYXNTcA?oc=5", "title": "Takeda Pharmaceutical to exit cell therapy research", "content_text": "Takeda Pharmaceutical to exit cell therapy research", "date_published": "2025-10-01T07:00:00+00:00", "authors": [{"name": "Reuters"}], "tags": ["Market update", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}, {"id": "source:083aacc893838a1b7c8f5c9360e21c179670d334d01ea3348f14ac3b5bad80cd", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQTjRCX1k4WlZsbHRBU3FWYWVJSVdJa3hQX1NlbTA1c29DUFpubjVtSnlQOHo0S0ExWnZQTUljZWhja05oc01aRDB0cERmOUs5WkZoeEFYNDkxN2EtRWdUdkNRTG9QbW13djhXbDdTd19wd19nNmUxOXNLOE5GUUJ2Sl8ybXpNaDZCdVIydGRCcm9zQjRyLTVuVFFzQ3VFOF81R0QwZXZXSHd3Y3FSeWRxaGtPWGRONU9MeHFKMlZZUjV0Zw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQTjRCX1k4WlZsbHRBU3FWYWVJSVdJa3hQX1NlbTA1c29DUFpubjVtSnlQOHo0S0ExWnZQTUljZWhja05oc01aRDB0cERmOUs5WkZoeEFYNDkxN2EtRWdUdkNRTG9QbW13djhXbDdTd19wd19nNmUxOXNLOE5GUUJ2Sl8ybXpNaDZCdVIydGRCcm9zQjRyLTVuVFFzQ3VFOF81R0QwZXZXSHd3Y3FSeWRxaGtPWGRONU9MeHFKMlZZUjV0Zw?oc=5", "title": "Japan's Takeda Pharma to restructure after annual profit slump", "content_text": "Japan's Takeda Pharma to restructure after annual profit slump", "date_published": "2024-05-09T07:00:00+00:00", "authors": [{"name": "Reuters"}], "tags": ["Earnings", "4502"], "_sharemaestro": {"country": "Japan", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "sentiment_url": "https://sharemaestro.com/sentiment/acc77fe3-1c93-46f3-a9a1-1d4d33093d4e/"}]}}]}